Global COPD market size to grow $35.9 billion by 2030

Getty Images 1367515302

The global chronic obstructive pulmonary disease (COPD) market size to grow from $18.2 billion in 2021 to $35.9 billion by 2030. The rise in the cases of COPD among population across the globe is one of the most important drivers expected to intensify this growth. The rise in consumption of tobacco among youth population and increase in the awareness among population about the use of generic drug are also expected to contribute to the growth in the global market over the forecast period. 

Market Trends

The need for COPD management is growing as the disease burden grows. Smoking tobacco may increase the risk of COPD. Adult smoker addiction has been on the rise all around the world. Workplace pollution and indoor air pollution are additional risk factors. Exposure to tobacco smoke is the main cause of COPD, according to the World Health Organization (WHO). The organization estimates that 3.23 million deaths will be caused by COPD, making it the third greatest cause of death worldwide. Almost 90% of COPD fatalities in people under 70 years of age take place in low- and middle-income nations.

The chronic bronchitis segment is dominating the market with largest market share over the forecast period.

On the basis of COPD type, the global COPD market is segmented into chronic bronchitis and emphysema. Among these, the chronic bronchitis segment is dominating the market with largest market share over the forecast period. Globally, the incidence and prevalence of chronic bronchitis are increasing as a result of rising cigarette use, greater industrialization and the release of hazardous chemicals into the environment. These factors have an impact on the increase in chronic bronchitis instances, which is driving the growth of this market.

The drugs segment accounted the highest market share over the forecast period.

Based on the treatment type, the global COPD market is segmented into drugs, oxygen therapy, surgery and others. Among these, the drugs segment accounted the highest market share over the forecast period. The increased use of medications as the first line of treatment for COPD to relieve breathing by opening up airways has further propelled the market expansion of this category.

The hospitals segment is dominating the market with the largest market share over the forecast period.

On the basis of the end user, the global COPD market is segmented into hospitals, clinics, home care settings and others. Among these, the hospitals segment is dominating the market with the largest market share over the forecast period because the prevalence of many chronic respiratory diseases and lifestyle disorders is increasing, as is public awareness of these illnesses. Also, the availability of various diagnostic and treatment facilities, higher purchasing power and the presence of highly skilled health care professionals are encouraging the growth of the hospital segment of the worldwide COPD market.

For more information, visit Global Chronic Obstructive Pulmonary Disease Market Size

More in COPD
Page 1 of 13
Next Page